Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells-Reference-Cited by-同舟云学术

Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells

Published:2020-05-15 Issue:10 Volume:41 Page:1357-1365
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Zhang Le-le,Lu Jun,Liu Rui-qi,Hu Min-juan,Zhao Yi-ming,Tan Sheng,Wang Shu-yuan,Zhang Bo,Nie Wei,Dong Yu,Zhong Hua,Zhang Wei,Zhao Xiao-dong,Han Bao-hui

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/s41401-020-0421-7.pdf

Reference43 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

2. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–89.

3. Zhang LL, Kan MY, Zhang MM, Yu SS, Xie HJ, Gu ZH, et al. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer. Int J Cancer. 2017;140:103–8.

4. Han B, Li K, Zhao Y, Li B, Cheng Y, Zhou J, et al. Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302). Br J Cancer. 2018;118:654–61.

5. Han B, Li K, Wang Q, Zhang L, Shi J, Wang Z, et al. Effect of anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer: the ALTER 0303 phase 3 randomized clinical trial. JAMA Oncol. 2018;4:1569–75.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFAP2A downregulation mediates tumor-suppressive effect of miR-8072 in triple-negative breast cancer via inhibiting SNAI1 transcription;Breast Cancer Research;2024-06-18

2. Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer;Aging;2024-01-23

3. Investigating the Hub Genes of Lactic Acid Bacterial Peptides and their association with Anti-Cancer Role;Biomedical and Pharmacology Journal;2023-12-31

4. A rapid and stable spontaneous reprogramming system of Spermatogonial stem cells to Pluripotent State;Cell & Bioscience;2023-12-01

5. Immune Cell Infiltration and Clinical Significance of Angiogenesis-related Genes in Lung Adenocarcinoma;Anticancer Research;2023-09-29